Related Experiment Video
Updated: Jul 19, 2026

04:08
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
Progress in familial Parkinson's disease
Summary
Familial Parkinson's disease (PD) involves 6 identified causative genes, with mutations leading to either dominant or recessive forms. Familial PD often presents with earlier onset and slower progression than sporadic PD.
Area of Science:
- Genetics
- Molecular Biology
- Neurodegenerative Diseases
Background:
- Familial Parkinson's disease (PD) comprises 11 mapped chromosomal loci, with 6 confirmed causative genes identified.
- These genes include alpha-synuclein (SNCA), parkin, UCH-L1, PINK1, DJ-1, and LRRK2.
- Mutations in SNCA, UCH-L1, and LRRK2 result in autosomal dominant PD, while others cause autosomal recessive PD.
Purpose of the Study:
- To review recent advancements in the genetics and molecular biology of familial Parkinson's disease.
- To explore the relationships between proteins encoded by familial PD genes.
- To consolidate current knowledge on genetic factors contributing to PD.
Main Methods:
- Literature review of genetic and molecular biology studies on familial PD.
- Analysis of identified gene mutations and their inheritance patterns (dominant vs. recessive).
- Comparison of clinical features, such as age of onset and disease progression, between familial and sporadic PD.
Main Results:
- Six genes (SNCA, parkin, UCH-L1, PINK1, DJ-1, LRRK2) are identified as causative for familial PD.
- Autosomal dominant forms are linked to SNCA, UCH-L1, and LRRK2; autosomal recessive forms are linked to the remaining genes.
- Familial PD typically shows an earlier age of onset, particularly recessive forms, and a slower disease progression with good levodopa response.
Conclusions:
- Significant progress has been made in identifying genetic underpinnings of familial PD.
- Understanding the interplay of familial PD-associated proteins is crucial for future research.
- Genetic factors play a key role in the diverse clinical presentations of Parkinson's disease.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
